HRT Financial’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58K Buy
+36,450
New +$269K ﹤0.01% 3737
2021
Q4
Sell
-2,927
Closed -$236K 3799
2021
Q3
$236K Sell
2,927
-1,622
-36% -$142K ﹤0.01% 2570
2021
Q2
$438K Buy
4,549
+1,460
+47% +$149K ﹤0.01% 1895
2021
Q1
$371K Buy
+3,089
New +$447K ﹤0.01% 1989

Other funds holding NXTC

HRT Financial's NXTC Position: Q2 2026 in Review

HRT Financial opened a new position in NextCure (NXTC) in Q2 2026: 36,450 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #3737 among its holdings. This is a return to the name: HRT Financial previously reported a position in NXTC as recently as Q3 2021.

HRT Financial first reported a position in NXTC in Q1 2021 and has held it in 4 quarters since. The position peaked at $438K in Q2 2021. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

  • HRT Financial held 36,450 shares of NextCure worth $58K as of Q2 2026.
  • NextCure was a new HRT Financial position in Q2 2026.
  • NextCure made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3737 holding.
  • HRT Financial first reported a position in NextCure in Q1 2021 and has held it in 4 quarters since.
  • HRT Financial's NextCure position peaked at $438K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.